| 注册
首页|期刊导航|中国医学创新|奈达铂化疗联合同期放疗治疗中晚期宫颈癌临床疗效分析

奈达铂化疗联合同期放疗治疗中晚期宫颈癌临床疗效分析

任玲

中国医学创新Issue(2):50-52,3.
中国医学创新Issue(2):50-52,3.DOI:10.3969/j.issn.1674-4985.2015.02.018

奈达铂化疗联合同期放疗治疗中晚期宫颈癌临床疗效分析

The Clinical Effects of Advanced Cervical Carcinoma by Nedaplatin Combine with Concurrent Chemoradiotherapy

任玲1

作者信息

  • 1. 辽宁省鞍山市肿瘤医院 鞍山市第四医院 辽宁 鞍山 114036
  • 折叠

摘要

Abstract

Objective:To explore the clinical effects of advanced cervical carcinoma by nedaplatin combine with concurrent chemoradiotherapy.Method: 135 cases of patients with advanced cervical carcinoma were randomly divided into group A, group B and group C,45 cases in each group. The group A was treated by nedaplatin combine with concurrent chemoradiotherapy, the group B was treated by cisplatin combine with concurrent chemoradiotherapy, the group C was treated by radiation. The clinical effects and adverse reactions were compared.Result: There was no significant difference on the total effective rate for group A and group B(P>0.05). The total effective rate for group A and group B were higher than group C, the difference was statistically significant(P<0.05). The rate of adverse reactions of I~IV for the group A were lower than the group B,the difference was statistically significant (P<0.05). The rate of adverse reactions of I for the group A were lower than the group B,the difference was statistically significant (P<0.05).Conclusion: The clinical effects of advanced cervical carcinoma by nedaplatin combine with concurrent chemoradiotherapy is good, it has high clinical effects, with low adverse reactions. It is worthy of clinical promotion.

关键词

奈达铂/化疗/放疗/中晚期宫颈癌/临床疗效

Key words

Nedaplatin/Chemotherapy/Radiation/Advanced cervical carcinoma/Clinical effects

引用本文复制引用

任玲..奈达铂化疗联合同期放疗治疗中晚期宫颈癌临床疗效分析[J].中国医学创新,2015,(2):50-52,3.

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文